Management Board and Supervisory Board plan share buyback to partially distribute proceeds from the sale of aap Biomaterials GmbH

In connection with the resolution on their proposals to the ordinary annual general meeting of the company Management Board and Supervisory Board of aap Implantate AG decided today to implement a share buyback within the next months in order to partially distribute proceeds from last year’s sale of the subsidiary aap Biomaterials GmbH to shareholders as announced. Based on the current share price level of the aap share it is intended within the share buyback to purchase up to 2.4 million shares of the company from the shareholders for a maximum total purchase price (including incidental costs) of up to EUR 3.5 million. The further details of the share buyback, including the purchase price, will be determined and published by the Management Board with the consent of the Supervisory Board within the next weeks. If market circumstances or the share price development changes the Management Board reserves the right to adapt the conditions of the intended share buyback or refrain from it. Against the background of the intended share buyback Management Board and Supervisory Board will neither propose a dividend payment nor a capital decrease to the annual general meeting taking place on 16 June 2017 – both measures have been taken into consideration for the partial distribution of proceeds from the sale of aap Biomaterials GmbH as well. The proposals from Management Board and Supervisory Board to the annual general meeting will be published together with the convention on 10 May 2017 in the Federal Gazette.